Morcillo Bellido, JesúsMerino Fuentes RamónMorcillo García, Jesús2026-03-112026-03-112023-03-25Morcillo-Bellido, J.J., Merino-Fuentes, R., Morcillo-García, J. (2023). Industry 4.0 in Large Pharma Companies. In: García Márquez, F.P., Segovia Ramírez, I., Bernalte Sánchez, P.J., Muñoz del Río, A. (eds) IoT and Data Science in Engineering Management. CIO 2022. Lecture Notes on Data Engineering and Communications Technologies, vol 160. Springer, Cham. https://doi.org/10.1007/978-3-031-27915-7_24978-3-031-27915-7https://doi.org/10.1007/978-3-031-27915-7_24https://hdl.handle.net/20.500.14468/32075The registered version of this conference paper is available online at the publisher's website: https://doi.org/10.1007/978-3-031-27915-7_24La versión registrada de esta conferencia está disponible en línea en el sitio web del editor: https://doi.org/10.1007/978-3-031-27915-7_24The term Industry 4.0 (I4.0) refers to an innovative industrial model based on the widespread application of digitalization and monitoring of different operational processes. The aim of this study is to gain a deeper understanding I4.0 impact on a sample of large companies in the pharma sector. From the analyses carried out, it could be inferred that the adoption of the new industrial model could enable and facilitate an increase on company´s customer responsiveness, through efficiency improvement along their supply chains and their level of innovation and service.eninfo:eu-repo/semantics/closedAccess5311 Organización y dirección de empresasactas de congresoIndustry 4.0Pharma sectorIndustry 4.0 in pharma